(Q45729692)

15 December 2017

Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection (English)

1 reference

15 December 2017

1 reference

1 reference

8

1 reference

15 December 2017

7

Michael Houghton

1 reference

15 December 2017

Francesca Masciopinto

1

object named as

Francesca Masciopinto

1 reference

15 December 2017

5

Luisa Galli-Stampino

1 reference

15 December 2017

9

Yasushi Uematsu

1 reference

15 December 2017

Giulia Freer

2

1 reference

15 December 2017

Vito L Burgio

3

1 reference

15 December 2017

Shoshana Levy

4

1 reference

15 December 2017

Mauro Bendinelli

6

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

15 December 2017

1 reference

15 December 2017

304

1 reference

15 December 2017

2

1 reference

15 December 2017

187-196

1 reference

Binding of hepatitis C virus to CD81

15 December 2017

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.282.5390.938

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Infection of human hepatocyte cell lines with hepatitis C virus in vitro

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Normal lymphocyte development but delayed humoral immune response in CD81-null mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Crystallization and preliminary crystallographic studies on the large extracellular domain of human CD81, a tetraspanin receptor for hepatitis C virus.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Multicycle infection of hepatitis C virus in cell culture and inhibition by alpha and beta interferons

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Lack of susceptibility of the cottontop tamarin to hepatitis C infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Establishment of persistent hepatitis C virus infection and replication in vitro.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Infection of a chimpanzee with hepatitis C virus grown in cell culture

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Low density lipoprotein receptor as a candidate receptor for hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

In vitro infection of peripheral blood mononuclear cells by hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Detection of a 5' UTR variation in the HCV genome after a long-term in vitro infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Differential expression of murine CD81 highlighted by new anti-mouse CD81 monoclonal antibodies

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Structure-function analysis of hepatitis C virus envelope-CD81 binding

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Susceptibility of human and non-human cell lines to HCV infection as determined by the centrifugation-facilitated method

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Hepatitis C virus population dynamics in human lymphocytes and hepatocytes infected in vitro

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Changes in HCV viremia following LDL apheresis in a HCV positive patient with familial hypercholesterolemia.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

The human bone-marrow-derived B-cell line CE, susceptible to hepatitis C virus infection.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.2002.1631

Identifiers

DOI

10.1006/VIRO.2002.1631

1 reference

15 December 2017

1 reference